Capecitabine monotherapy does not improve survival in elderly patients with early-stage breast cancer

IBIS-I trial: tamoxifen lowered breast cancer rates among high-risk women

Best of ASH 2014

ASH 2014: Highlights in CLL from ASH 2014

Busulfan exposure dose tested for MDS and AML

Oprozomib shows potential in the treatment of multiple myeloma

Ibrutinib as a single agent and in combination with dexamethasone showed anti-tumour activity in multiple myeloma

Hope for avoiding chemo in patients with Hodgkins lymphoma

Combination therapy for high-risk MDS? Not quite yet

Should young adults with acute lymphocytic leukaemia receive paediatric treatment protocols?

Results of HD2000 trial comparing combination therapies in advanced-stage Hodgkin's lymphoma

Characterising the findings of the peripheral T-cell lymphoma registry